CKCheol Yong Kim

Cheol Yong Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cheol Yong Kim has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Dae Sik Yang

    Departments of Radiation Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea

    1 shared publication
  • Dong-Hyuk Park

    Department of Neurosurgery, Korea University Anam Hospital, College of Medicine, Korea University, Seoul, Korea

    1 shared publication
  • Dongho Geum

    Department of Medical Science, College of Medicine, Korea University, Seoul, Korea

    1 shared publication
  • Hwa Jeong Seong

    Internal Medicine, Ansan Hospital College of Medicine, Korea University Ansan Seoul Republic of Korea

    1 shared publication
  • Jae Jeong Shim

    Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea

    1 shared publication
  • Jae Youn Cho

    Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea

    1 shared publication

Latest Publications

  • Open Access

    Neuroprotective Effects of Human Adipose Tissue-Derived Mesenchymal Stromal Cells Against Radiation-Induced Neural Damage : A Comparative In Vitro Study

    by Jang Hun Kim, Chul Young Kim, Jong-Hoon Kim, Dongho Geum, Dong-Hyuk Park

    Objective : Radiotherapy is a key treatment for brain tumors and arteriovenous malformations; however, it is associated with adverse effects such as brain edema, demyelination, and delayed necrosis. These adverse effects are driven by inflammation and apoptosis, initiated by cytokines such as tumor necrosis factor-α, transforming growth factor, and interleukin-1β. Adipose tissuederived mesenchymal stromal cells (ADMSCs) offer protection against radiation-induced damage owing to their pluripotency and antiinflammatory properties. In this study, we investigated the neuroprotective effects of ADMSCs on irradiated brain cells.Methods : Rat cortical neurons, human glioblastoma cells (U87 cell line), and ADMSCs were exposed to radiation doses ranging from 3 Gy to 40 Gy. Co-cultures of irradiated neurons with ADMSCs or their secretomes were assessed for apoptotic and inflammatory markers. Cell viability was measured using lactate dehydrogenase (LDH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Apoptosis was determined by using Hoechst staining and western blot analysis of proteins such as Bax, caspase-3, and Bcl-2.Results : Higher radiation doses (30–40 Gy) significantly increased apoptosis and decreased the viability of cortical neurons and U87 cells. Co-culture with ADMSCs reduced the levels of apoptosis markers, particularly Bax and cleaved caspase-3, and promoted cell survival. Direct co-culture provided more pronounced protection than did ADMSC secretome treatment, suggesting that cell-to-cell interactions are crucial for neuroprotection.Conclusion : ADMSCs have a significant potential for mitigating radiation-induced brain damage by reducing apoptosis and inflammation. Direct ADMSC co-culture outperformed secretome treatment, thereby emphasizing the importance of physical cell interactions. ADMSC therapy may be a promising approach to protect against radiotherapy-induced neural damage. Further studies are required to optimize the delivery and timing of stem cell therapy.


  • Treatment interruption during radiation therapy: Experience at a single institution in the Republic of Korea

    by Jung Ae Lee, Nam Kwon Lee, Won Sup Yoon, Dae Sik Yang, Chul Yong Kim, Se Ryun Lee, Hwa Jeong Seong

    Aim: Our study analyzed the frequency and causes of treatment interruption among patients undergoing radiation therapy (RT).Methods: A total of 1637 RT courses in 1500 patients were reviewed from September 2009 to October 2013. A continuous break over 7 days or a discontinuous break over 14 days was regarded as a temporary break and RT under 80% of planned treatment was regarded as incomplete.Results: Two‐hundred and twenty courses (13.4%) with treatment interruption were identified. Half of the patients received RT with a definitive aim, and the other half for palliative care. Completion after temporary break, near completion and incompletion were noticed in 12.3%, 21.3%, and 66.4% of cases, respectively. Among patients with a definite aim, thorax (19.2%) and abdomen (16.3%) had a higher interruption rate. For brain and bone with a palliative aim, the frequency of interruption was about 16%. Old age and worse performance negatively affected interruption. The most common cause of treatment interruption was cancer progression including death (30%) and the next was treatment‐related side effects (23.1%).Conclusion: About 13% of RT cases were interrupted. Two third of patients received less than 80% of the planned RT. To improve RT completion rate, multidirectional efforts are needed.


  • Open Access

    The Effects of High Dose Rate Brachytherapy in Recurrent Obstructive Bronchogenic Cancer after External Irradiation Therapy

    by Jae Youn Cho, Kwang Ho In, Jung Kyung Suh, Sea Yong Kang, Jae Jeong Shim, Kyung Ho Kang, Se Hwa Yoo, Kwang Taek Kim, Cheol Yong Kim

    Cho JY, et al. Tuberc Respir Dis. 1998 Feb;45(1):68-76. http://dx.doi.org/10.4046/trd.1998.45.1.68